Colotta, F., et al. (2009). Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis, 30(7), 1073–1081.

Article  PubMed  CAS  Google Scholar 

Porter, R. J., et al. (2021). Inflammatory bowel disease-associated colorectal cancer: Translational risks from mechanisms to medicines. Journal of Crohn’s & Colitis, 15(12), 2131–2141.

Article  Google Scholar 

Li, J., et al. (2023). Colitis-associated carcinogenesis: Crosstalk between tumors, immune cells and gut microbiota. Cell & Bioscience, 13, 194.

Article  Google Scholar 

Dyson, J. K., & Rutter, M. D. (2012). Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk? World Journal of Gastroenterology, 18(29), 3839–3848.

Article  PubMed  PubMed Central  Google Scholar 

Kong, D.-H., et al. (2018). Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. International Journal of Molecular Sciences, 19(4), 1057.

Article  PubMed  PubMed Central  Google Scholar 

Singh, V., et al. (2023). ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders. Clinica Chimica Acta, 548,

Article  CAS  Google Scholar 

Guan, Q. (2019). A comprehensive review and update on the pathogenesis of inflammatory bowel disease. Journal of Immunology Research, 2019,

Zhang, Y.-Z., & Li, Y.-Y. (2014). Inflammatory bowel disease: Pathogenesis. World Journal of Gastroenterology, 20(1), 91–99.

Article  PubMed  PubMed Central  Google Scholar 

Yadav, V., et al. (2016). Inflammatory bowel disease: Exploring gut pathophysiology for novel therapeutic targets. Trans. Res., 176, 38–68.

Article  CAS  Google Scholar 

Moreau, J., & Mas, E. (2015). Drug resistance in inflammatory bowel diseases. Current Opinion in Pharmacology, 25, 56–61.

Article  PubMed  CAS  Google Scholar 

Chang, J. T. (2020). Pathophysiology of inflammatory bowel diseases. New England Journal of Medicine, 383(27), 2652–2664.

Article  PubMed  CAS  Google Scholar 

Shim, J. A. et al. (2023). The role of gut microbiota in T cell immunity and immune mediated disorders. International Journal of Biological Sciences, 19(4), 1178–1191.

Tindemans, I., Joosse, M. E., & Samsom, J. N. (2020). Dissecting the heterogeneity in T-cell mediated inflammation in IBD. Cells, 9(1), 110.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Salmi, M., & Jalkanen, S. (2005). Lymphocyte homing to the gut: Attraction, adhesion, and commitment. Immunological Reviews, 206, 100–113.

Article  PubMed  CAS  Google Scholar 

Marsal, J., & Agace, W. W. (2012). Targeting T-cell migration in inflammatory bowel disease. Journal of Internal Medicine, 272(5), 411–429.

Article  PubMed  CAS  Google Scholar 

Zundler, S., et al. (2019). Immune cell trafficking and retention in inflammatory bowel disease: Mechanistic insights and therapeutic advances. Gut, 68(9), 1688–1700.

Article  PubMed  CAS  Google Scholar 

Imam, T., et al. (2018). Effector T helper cell subsets in inflammatory bowel diseases. Frontiers in Immunology, 9, 1212.

Article  PubMed  PubMed Central  Google Scholar 

Mármol, I., et al. (2017). Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. International Journal of Molecular Sciences, 18(1), 197.

Article  PubMed  PubMed Central  Google Scholar 

Ponz de Leon, M., & Di Gregorio, C. (2001). Pathology of colorectal cancer. Digestive and Liver Disease, 33(4), 372–388.

Grivennikov, S. I., & Cominelli, F. (2016). Colitis-associated and sporadic colon cancers: Different diseases, different mutations? Gastroenterology, 150(4), 808–810.

Article  PubMed  Google Scholar 

Maryńczak, K., et al. (2022). Colitis-associated colorectal cancer in patients with inflammatory bowel diseases in a tertiary referral center: A propensity score matching analysis. Journal of Clinical Medicine, 11(3), 866.

Article  PubMed  PubMed Central  Google Scholar 

Keum, N. N., & Giovannucci, E. (2019). Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nature Reviews. Gastroenterology & Hepatology, 16, 713–732.

Article  Google Scholar 

Yamamoto, T., Kawada, K., & Obama, K. (2021). Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. International Journal of Molecular Sciences, 22(15), 8002.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Maniewska, J., & Jeżewska, D. (2021). Non-steroidal anti-inflammatory drugs in colorectal cancer chemoprevention. Cancers (Basel), 13(4), 594.

Article  PubMed  CAS  Google Scholar 

Kuipers, E. J., et al. (2015). Colorectal cancer. Nat. Rev. Dis. Primers, 1, 15965.

Google Scholar 

Van Schaeybroeck, S., et al. (2014). Colorectal cancer. In J. E. Niederhuber, et al. (Eds.), Abeloff’s clinical oncology (pp. 1278–1335). Elsevier.

Chapter  Google Scholar 

Baker, A.-M., et al. (2019). Evolutionary history of human colitis-associated colorectal cancer. Gut, 68(6), 985–995.

Article  PubMed  CAS  Google Scholar 

Zhao, H., et al. (2021). Inflammation and tumor progression: Signaling pathways and targeted intervention. Sig. Transduct. Target. Ther., 6, 263.

Article  CAS  Google Scholar 

Moossavi, S., & Bishehsari, F. (2012). Inflammation in sporadic colorectal cancer. Archives of Iranian Medicine, 15(3), 166–170.

PubMed  CAS  Google Scholar 

Granger, D.N., C.G. Kevil, and M.B. Grisham, Recruitment of inflammatory and immune cells in the gut: Physiology and pathophysiology, in Physiology of the gastrointestinal tract, L.R. Johnson, et al., Editors. 2012, Elsevier.

Ulyanova, T., et al. (2005). VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin. Blood, 106(1), 86–94.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Van Heyst, K. A., et al. (2022). Ectopic tumor VCAM-1 expression in cancer metastasis and therapy resistance. Cells, 11(23), 3922.

Article  Google Scholar 

Cook-Mills, J. M., Marchese, M. E., & Abdala-Valencia, H. (2011). Vascular cell adhesion molecule-1 expression and signaling during disease: Regulation by reactive oxygen species and antioxidants. Antioxidants & Redox Signaling, 15(6), 1607–1638.

Article  CAS  Google Scholar 

Broide, D.H. and P. Sriramaro, Cellular adhesion in inflammation, in Middleton’s allergy: Principles & practice, N.F. Adkinson, Jr. , et al., Editors. 2014, Elsevier.

Chakraborty, S., et al. (2015). The interaction affinity between vascular cell adhesion molecule-1 (VCAM-1) and very late antigen-4 (VLA-4) analyzed by quantitative FRET. PLoS ONE, 10(3)

Article  PubMed  PubMed Central  Google Scholar 

Postigo, A. A., et al. (1993). Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes. Journal Immunologica, 151(5), 2471–2483.

Barthel, S. R., et al. (2006). Differential engagement of modules 1 and 4 of vascular cell adhesion molecule-1 (CD106) by integrins α4β1 (CD49d/29) and αMβ2 (CD11b/18) of eosinophils. Journal of Biological Chemistry, 281(43), 32175–32187.

Article  PubMed  CAS  Google Scholar 

Taooka, Y., et al. (1999). The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. Journal of Cell Biology, 145(2), 413–420.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Van der Vieren, M., et al. (1999). The leukocyte integrin alpha D beta 2 binds VCAM-1: Evidence for a binding interface between I domain and VCAM-1. The Journal of Immunology, 15(4), 1934–1990.

Google Scholar 

Kaur, G., et al. (2023). Vascular cell-adhesion molecule 1 (VCAM-1) regulates JunB-mediated IL-8/CXCL1 expression and pathological neovascularization. Commun. Biol., 6, 516.

Article